Ample evidence suggests that an imbalance in dopaminergic tone impacts the expression levels of neuropeptides like somatostatin (SST) and neuropeptide Y (NPY), as seen in patients with Parkinson’s disease and HD as well as in rodent models15–18. This evidence concerns the gene SST and Parkinson disease.